PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
Seeking Alpha / 2 hours from now 1 Views
Seeking Alpha / 2 hours from now 1 Views
PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated
Comments